Literature DB >> 16236852

Difficulties identifying and targeting COPD and population-attributable risk of smoking for COPD: a population study.

David Wilson1, Robert Adams, Sarah Appleton, Richard Ruffin.   

Abstract

STUDY
OBJECTIVES: Respiratory public health interventions depend on accurate identification of the target group, yet this may vary depending on the diagnostic criteria used. We therefore compared the relative performance of various international criteria in identifying COPD cases. The burden of COPD due to smoking can only be determined from population-attributable risk (PAR) studies. These studies, lacking in the COPD literature, are necessary research in support of public health initiatives for COPD. In this representative population study, we also assessed the PAR for current and ex-smokers.
DESIGN: A representative biomedical population sample of 2,501 South Australians aged > or = 18 years (The Northwest Adelaide Health [Cohort] Study). COPD diagnosis and severity were determined according to various FEV1/FVC and FEV1 percentage of predicted criteria recommended by international respiratory authorities. Demographic, health behavior, and quality-of-life data were obtained by telephone interview and self-completed questionnaire.
SETTING: Northwest Adelaide. MEASUREMENTS AND
RESULTS: The PAR of smoking (smokers and ex-smokers) for COPD ranged from 51 to 70% depending on the diagnostic respiratory criteria used. COPD prevalence varied depending on the criteria used: American Thoracic Society, 5.4%; British Thoracic Society, 3.5%; European Respiratory Society (ERS), 5.0%; Global Initiative for Chronic Obstructive Lung Disease, 5.4%. There was also substantial disagreement in the cases identified. An alternative approach using ERS reference values one residual SD from the mean produced a COPD prevalence estimate of 6.9%, with improved level of agreement with the established respiratory criteria suggesting their potential as screening criteria.
CONCLUSIONS: The COPD risks associated with smoking and ex-smoking history were quantifiable using PAR, but PAR also suggests other, yet unquantified, risks. Targeting COPD cases for public health interventions is difficult given the range of spirometry criteria and the associated high level of underdiagnosis.

Entities:  

Mesh:

Year:  2005        PMID: 16236852     DOI: 10.1378/chest.128.4.2035

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

Review 1.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

2.  Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample.

Authors:  L Shahab; M J Jarvis; J Britton; R West
Journal:  Thorax       Date:  2006-10-13       Impact factor: 9.139

3.  Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project.

Authors:  Richard Hooper; Peter Burney; William M Vollmer; Mary Ann McBurnie; Thorarinn Gislason; Wan C Tan; Anamika Jithoo; Ali Kocabas; Tobias Welte; A Sonia Buist
Journal:  Eur Respir J       Date:  2011-12-19       Impact factor: 16.671

4.  Risk factors for community-acquired pneumonia in German adults: the impact of children in the household.

Authors:  M Schnoor; T Klante; M Beckmann; B P Robra; T Welte; H Raspe; T Schäfer
Journal:  Epidemiol Infect       Date:  2007-02-12       Impact factor: 2.451

5.  Regional differences in prediction models of lung function in Germany.

Authors:  Eva Schnabel; Chih-Mei Chen; Beate Koch; Stefan Karrasch; Rudolf A Jörres; Torsten Schäfer; Claus Vogelmeier; Ralf Ewert; Christoph Schäper; Henry Völzke; Anne Obst; Stephan B Felix; H-Erich Wichmann; Sven Gläser; Joachim Heinrich
Journal:  Respir Res       Date:  2010-04-22

6.  [The prevalence of COPD in Austria--the expected change over the next decade].

Authors:  Natalie Firlei; Bernd Lamprecht; Lea Schirnhofer; Bernhard Kaiser; Michael Studnicka
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

7.  Multimorbidity - not just an older person's issue. Results from an Australian biomedical study.

Authors:  Anne W Taylor; Kay Price; Tiffany K Gill; Robert Adams; Rhiannon Pilkington; Natalie Carrangis; Zumin Shi; David Wilson
Journal:  BMC Public Health       Date:  2010-11-22       Impact factor: 3.295

Review 8.  Improved patient outcome with smoking cessation: when is it too late?

Authors:  Jane Wu; Don D Sin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-05-02

9.  Second-hand smoke and chronic bronchitis in Taiwanese women: a health-care based study.

Authors:  Chia-Fang Wu; Nan-Hsiung Feng; Inn-Wen Chong; Kuen-Yuh Wu; Chien-Hung Lee; Jhi-Jhu Hwang; Chia-Tsuan Huang; Chung-Ying Lee; Shao-Ting Chou; David C Christiani; Ming-Tsang Wu
Journal:  BMC Public Health       Date:  2010-01-28       Impact factor: 3.295

10.  An analysis of the economic impact of smoking cessation in Europe.

Authors:  David Cohen; M Fasihul Alam; Paul S Jarvis
Journal:  BMC Public Health       Date:  2013-04-25       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.